Core Scientific Stock Is Worth Watching After CoreWeave HPC Deal

• Core Scientific recently highlighted its shift toward high performance computing data centers, anchored by a 12 year, US$8.7b hosting contract with CoreWeave that is expected to reshape its revenue mix away from Bitcoin mining.
• The long term CoreWeave agreement signals that Core Scientific’s infrastructure is being repositioned for AI and HPC demand, which could change how investors weigh concentration risk, capital needs, and the trade off between hosting and self mining economics.
• We will explore how Core Scientific's investment narrative is affected by this long term CoreWeave HPC contract and the AI infrastructure pivot.

Scan beyond Core Scientific to see which other AI infrastructure players are lining up contracts and capacity in our curated list of 55 AI infrastructure stocks.

Core Scientific Investment Narrative Recap

To own Core Scientific, you need to believe the pivot from Bitcoin mining toward high performance computing builds a more durable infrastructure business. The immediate focus is on whether AI and data center hosting can offset pressure in digital asset mining. The recent share price rebound after a steep four week slide simply underlines how sensitive the stock is to expectations around that shift.

The short term catalyst is execution on HPC build out and evidence that losses are narrowing from the US$265 million reported in Q4 2024. The biggest risk remains concentration around CoreWeave and a balance sheet with less than one year of cash runway and negative equity, which keeps funding and contract delivery front and center.

The 12 year, US$8.7b CoreWeave agreement is the operational anchor for this story. That contract links a large portion of future hosting revenue to a single customer, so every update on deployment timelines or capacity utilization feeds directly into the Core Scientific investment case. Share price swings over the past year show how quickly sentiment moves when investors reassess that dependency.

This same announcement also frames the key catalyst. If Core Scientific can turn that backlog into functioning AI and HPC sites, then forecasts for faster revenue expansion and a path toward profitability have more support. Execution setbacks, such as permitting delays or equipment bottlenecks, would cut the other way and amplify existing concerns about concentration and funding needs.

Core Scientific's current earnings are a loss of US$1.6b, and analysts project revenue of US$2.2b and earnings of US$388.4 million by 2029, which implies forecast yearly revenue growth of 69.8% and an earnings swing of roughly US$2.0b from today to the 2029 consensus estimate.

Uncover why Core Scientific's fair value indicates a 152% potential upside to its current price that could narrow quickly.

Exploring Other Perspectives

One alternate angle on Core Scientific focuses on the most optimistic take around earnings power from AI contracts. Before this news, the highest analysts were already penciling in revenue of US$3.5b and earnings of US$1.3b by 2029. Those upbeat forecasts have not yet absorbed the latest share move, so views could shift sharply from here. Investors can read this as a reminder that opinions on Core Scientific’s future spread widely, and it is worth testing several narratives against personal expectations.

Explore 2 other Core Scientific fair value estimates, including one that suggests as much as 249% upside from the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so trust your own analysis and judgment.

• A great starting point for your Core Scientific research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• See our latest analysis for Core Scientific. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Core Scientific's overall financial health at a glance.

Looking for more investment ideas beyond Core Scientific?

Once you have formed a view on Core Scientific, it can help to compare it with other opportunities that fit your preferred style, whether you care more about quality, income, or resilience. The Simply Wall St Screener lets you filter the market quickly so you can focus on businesses that match your own criteria instead of scrolling through endless tickers.

• If you want to focus on stability first, filter for companies with stronger balance sheets and steady fundamentals using our list of solid balance sheet and fundamentals (25 results).
• For investors hunting for high quality companies that may be trading below what the numbers suggest, start with this curated set of 33 high quality undervalued stocks.
• If reliable income is a priority, narrow your search to stocks offering meaningful yields and robust payout profiles from our hand picked 8 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com